Tags

Type your tag names separated by a space and hit enter

Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status.

Abstract

We examined the association of dietary lignan intake with estrogen receptor negative (ER-) and ER positive (ER+) breast cancer risk in a breast cancer case-control study. Among premenopausal women only, there was a reduced risk of ER- breast cancer for those in the highest compared to the lowest quartile of lignan intake suggesting that the observed negative association of lignans with breast cancer may be limited to ER- tumors.

Links

  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    Department of Epidemiology, Division of Cancer Prevention and Population Sciences, Roswell Park Cancer Institute, Buffalo, NY, USA.

    , , , , , ,

    Source

    Breast cancer research and treatment 99:3 2006 Oct pg 309-11

    MeSH

    Adult
    Aged
    Breast Neoplasms
    Case-Control Studies
    Diet
    Female
    Humans
    Lignans
    Middle Aged
    New York
    Odds Ratio
    Phytoestrogens
    Postmenopause
    Premenopause
    Receptors, Estrogen
    Risk Assessment
    Risk Factors

    Pub Type(s)

    Journal Article
    Research Support, N.I.H., Extramural

    Language

    eng

    PubMed ID

    16541305

    Citation

    McCann, Susan E., et al. "Dietary Lignan Intakes and Risk of Breast Cancer By Tumor Estrogen Receptor Status." Breast Cancer Research and Treatment, vol. 99, no. 3, 2006, pp. 309-11.
    McCann SE, Kulkarni S, Trevisan M, et al. Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status. Breast Cancer Res Treat. 2006;99(3):309-11.
    McCann, S. E., Kulkarni, S., Trevisan, M., Vito, D., Nie, J., Edge, S. B., ... Freudenheim, J. L. (2006). Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status. Breast Cancer Research and Treatment, 99(3), pp. 309-11.
    McCann SE, et al. Dietary Lignan Intakes and Risk of Breast Cancer By Tumor Estrogen Receptor Status. Breast Cancer Res Treat. 2006;99(3):309-11. PubMed PMID: 16541305.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status. AU - McCann,Susan E, AU - Kulkarni,Swati, AU - Trevisan,Maurizio, AU - Vito,Dominica, AU - Nie,Jing, AU - Edge,Stephen B, AU - Muti,Paola, AU - Freudenheim,Jo L, Y1 - 2006/03/16/ PY - 2006/02/03/received PY - 2006/02/07/accepted PY - 2006/3/17/pubmed PY - 2007/1/20/medline PY - 2006/3/17/entrez SP - 309 EP - 11 JF - Breast cancer research and treatment JO - Breast Cancer Res. Treat. VL - 99 IS - 3 N2 - We examined the association of dietary lignan intake with estrogen receptor negative (ER-) and ER positive (ER+) breast cancer risk in a breast cancer case-control study. Among premenopausal women only, there was a reduced risk of ER- breast cancer for those in the highest compared to the lowest quartile of lignan intake suggesting that the observed negative association of lignans with breast cancer may be limited to ER- tumors. SN - 0167-6806 UR - https://www.unboundmedicine.com/medline/citation/16541305/Dietary_lignan_intakes_and_risk_of_breast_cancer_by_tumor_estrogen_receptor_status_ L2 - https://doi.org/10.1007/s10549-006-9196-x DB - PRIME DP - Unbound Medicine ER -